Abstrakt

Przypisy

• 1. Apfalter P., Blasi F., Boman J., Gaydos C.A., Kundi M., Maass M.,Makristathis A., Meijer A., Nadrchal R., Persson K., Rotter M.L, TongC.Y., Stanek G., Hirschi A.M.: Multicenter comparison trial of DNA extractionmethods and PCR assays for detection of Chlamydia pneumoniaein endarterectomy specimens. J. Clin. Microbiol., 2001; 39: 519-524
  Google Scholar
• 2. Axisa B., Naylor A.R., London N., Bell P.R., Thompson M.M.: Theinfluence of carotid plaque morphology on the development of cerebralsymptoms. Vasc. Endovascular. Surg., 2000; 34: 309-318
  Google Scholar
• 3. Boilly B., Vercoutter-Edouart A.S., Hondermarck H., Nurcombe V.,Le Bourhis X.: FGF signals for cell proliferation and migration throughdifferent pathways. Cytokine Growth Factor Rev., 2000; 11: 295-302
  Google Scholar
• 4. Chen J., Zhu M., Ma G., Zhao Z., Sun Z.: Chlamydia pneumoniaeinfection and cerebrovascular disease: a systematic review and metaanalysis.BMC Neurol., 2013; 13: 183
  Google Scholar
• 5. Choksy S., Pockley A.G., Wajeh Y.E., Chan P.: VEGF and VEGF receptorexpression in human chronic critical limb ischemia. Eur. J. Vasc.Endovasc. Surg., 2004; 28: 660-669
  Google Scholar
• 6. Coultas L., Chawengsaksophak K., Rossant J.: Endothelial cells andVEGF in vascular development. Nature, 2005; 438: 937-945
  Google Scholar
• 7. Di Pietro M., Filardo S., De Santis F., Sessa R.: Chlamydia pneumoniaeinfection in atherosclerotic lesion development through oxidativestress: a brief overview. Int. J. Mol. Sci., 2013; 14: 15105-15120
  Google Scholar
• 8. Epstein S.E., Zhu I., Burnett M.S., Zhou Y.F., Vercellotti G., Hajjar D.:Infection and atherosclerosis: potential roles of pathogen burden andmolecular mimicry. Arterioscler. Thromb. Vasc. Biol., 2000; 20: 1417-1420
  Google Scholar
• 9. Espinola-Klein C., Rupprecht H.J., Blankenberg S., Bickel C., KoppH., Rippin G., Hafner G., Pfeifer U., Meyer J.: Are morphological or functional changes in the carotid artery wall associated with Chlamydiapneumoniae, Helicobacter pylori, Cytomegalovirus, or HerpesSimplex Virus infection? Stroke, 2000; 31: 2127-2133
  Google Scholar
• 10. Farsak B., Yildirir A., Akyőn Y., Pinar A., ÖC M., Bőke E., Kes S.,Tokgozoglu L.: Detection of Chlamydia pneumoniae and Helicobacterpylori DNA in human atherosclerotic plaques by PCR. J. Clin. Microbiol.,2000; 38: 4408-4411
  Google Scholar
• 11. Gibbs R.G., Sian M., Mitchell A.W., Greenhalgh R.M., Davies A.H.,Carey N.: Chlamydia pneumoniae does not influence atheroscleroticplaque behavior in patients with established carotid artery stenosis.Stroke, 2000; 31: 2930-2935
  Google Scholar
• 12. Grosjean J., Kiriakidis S., Reilly K., Feldmann M., Paleolog E.:Vascular endothelial growth factor signalling in endothelial cellsurvival: a role for NFκB. Biochem. Biophys. Res. Commun., 2006;340: 984-994
  Google Scholar
• 13. Javerzat S., Auguste P., Bikfalvi A.: The role fibroblast growthfactors in vascular development. Trends. Mol. Med. 2002; 8: 483-489
  Google Scholar
• 14. Johnston S.C., Messina L.M., Browner W.S., Lawton M.T., MorrisC., Dean D.: C-reactive protein levels and viable Chlamydiapneumoniae in carotid artery atherosclerosis. Stroke, 2001; 32:2748-2752
  Google Scholar
• 15. Katsenis C., Kouskouni E., Kolokotronis L., Rizos D., DimakakosP.: The significance of Chlamydia pneumoniae in symptomatic carotidstenosis. Angiology, 2001; 52: 615-619
  Google Scholar
• 16. Lutgens E., Gijbels M., Smook M., Heeringa P., Gotwals P., KotelianskyV.E., Daemen M.J.: Transforming growth factor-β mediatesbalance between inflammation and fibrosis during plaque progression.Arterioscler. Thromb. Vasc. Biol., 2002; 22: 975-982
  Google Scholar
• 17. Makin A., Chung N., Silverman S., Lip G.Y.: Vascular endothelialgrowth factor and tissue factor in patients with established peripheralartery disease: a link between angiogenesis and thrombogenesis?Clin. Sci., 2003; 104: 397-404
  Google Scholar
• 18. Meijer A., Roholl P.J., Gielis-Proper S.K., Osserwaarde J.M.: Chlamydiapneumoniae antigens, rather than viable bacteria, persist inatherosclerotic lesions. J. Clin. Pathol., 2000; 53: 911-916
  Google Scholar
• 19. Mosorin M., Surcel H.M., Laurila A., Lehtinen M., Karttunen R.,Juvonen J., Paavonen J., Morrison R.P., Saikku P., Juvonen T.: Detectionof Chlamydia pneumoniae-reactive T lymphocytes in human atheroscleroticplaques of carotid artery. Arterioscler. Thromb. Vasc.Biol., 2000; 20: 1061-1067
  Google Scholar
• 20. Ngeh J., Anand V., Gupta S:. Chlamydia pneumoniae and atherosclerosis- what we know and what we don’t. Clin. Microbiol. Infect.,2002; 8: 2-13
  Google Scholar
• 21. Olsen S.K., Garbi M., Zampieri N., Eliseenkova A.V., Ornitz D.M.,Goldfarb M., Mohammadi M.: Fibroblast growth factor (FGF) homologousfactors share structural but not functional homology withFGFs. J. Biol. Chem., 2003; 278: 34226-34236
  Google Scholar

Pełna treść artykułu